Insmed (INSM) Profit After Tax (2010 - 2026)

Insmed's (INSM) quarterly Profit After Tax came in at -$1.5 million in Q1 2026, up 99.43% year-on-year from -$730574.3 in Q1 2025, and up 99.55% quarter-over-quarter from -$324.7 million in Q4 2025.

Insmed (INSM) Profit After Tax (2010 - 2026) Analysis & Trends

Insmed's Profit After Tax history runs 17 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

  • On a quarterly basis, Profit After Tax rose 99.43% year-over-year to -$1.5 million in Q1 2026; TTM through Mar 2026 was -$693.6 million, a 31.65% increase from a year earlier, with the FY2025 full-year figure at -$1.3 billion, down 39.08% from the prior year.
  • Profit After Tax climbed to -$1.5 million in Q1 2026 per INSM's latest filing, from -$324.7 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $562.0 million in Q4 2023 and bottomed at -$370.0 million in Q3 2025.
  • The 5-year median for Profit After Tax is -$157.8 million (2022), against an average of -$123.1 million.
  • Across the five-year window, Profit After Tax plunged 40517.9% in 2022 and jumped 456.22% in 2023, its largest moves.
  • Year by year, Profit After Tax stood at -$157.8 million in 2022, then soared by 456.22% to $562.0 million in 2023, then plunged by 142.19% to -$237.1 million in 2024, then sank by 36.97% to -$324.7 million in 2025, then surged by 99.55% to -$1.5 million in 2026.
  • Per Business Quant, the three latest INSM Profit After Tax figures stand at -$1.5 million (Q1 2026), -$324.7 million (Q4 2025), and -$370.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -36.84 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn -1.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.46 Mn
Dec 31, 2025 -324.74 Mn
Sep 30, 2025 -370.02 Mn
Jun 30, 2025 2.63 Mn
Mar 31, 2025 -256.58 Mn
Dec 31, 2024 -237.09 Mn
Sep 30, 2024 -220.52 Mn
Jun 30, 2024 -300.61 Mn
Mar 31, 2024 -157.09 Mn
Dec 31, 2023 562.01 Mn
Sep 30, 2023 -827,000.00
Jun 30, 2023 -244.81 Mn
Mar 31, 2023 -159.44 Mn
Dec 31, 2022 -157.77 Mn
Sep 30, 2022 -131.60 Mn
Jun 30, 2022 -699,000.00
Mar 31, 2022 -94.62 Mn
Dec 31, 2021 -433.79 Mn
Sep 30, 2021 -324,000.00
Jun 30, 2021 334,000.00